[Migraine, inflammation, genes. New risk factors for stroke].
D000328:Adult; D001161:Arteriosclerosis / Q000150:complications; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000032:analysis; D016022:Case-Control Studies; D003276:Contraceptives, Oral / Q000009:adverse effects; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005492:Folic Acid / Q000008:administration & dosage; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications / Q000188:drug therapy; D007249:Inflammation / Q000150:complications; D008297:Male; D015201:Meta-Analysis as Topic; D008881:Migraine Disorders / Q000150:complications; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D020521:Stroke / Q000209:etiology* / Q000235:genetics; D015912:Thrombolytic Therapy; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000008:administration & dosage; D025101:Vitamin B 6 / Q000008:administration & dosage
D003276:Contraceptives, Oral; D025101:Vitamin B 6; D005340:Fibrinogen; D002097:C-Reactive Protein; D005492:Folic Acid; D010959:Tissue Plasminogen Activator; D014805:Vitamin B 12; D001241:Aspirin
Migräne, Entzündungen, Gene. Neue Risikofaktoren für den Schlaganfall.